|
|
Market Analysis Reports of Istaroxime
|
Cardiogenic Shock - Pipeline Insight - 2020 ... . Cardiogenic Shock Emerging Drugs Istaroxime: Windtree Therapeutics Istaroxime is a first-in-class, dual action ... Therapeutics Leading BioSciences Key Products Istaroxime Tranexamic acid
Acute Heart Failure (AHF) Therapeutics: Market Research Report This report analyzes the worldwide markets for Next Generation Sequencers in US$ Thousand. The Global market is additionally analyzed by the following End-Use Segments: Pharmaceutical/Biotech, Industrial, and Government/Academia. The report provides ...
Windtree Therapeutics Inc (WINT) - Financial and Strategic SWOT Analysis Review ... company’s lead development programs are istaroxime, for treating acute decompensated heart ...
Windtree Therapeutics Inc - Strategy, SWOT and Corporate Finance Report ... . Its major development programs are istaroxime, Aerosurf, lyophilized KL4 surfactant, oral ...
Windtree Therapeutics Inc - Strategy, SWOT and Corporate Finance Report ... . Its major development programs are istaroxime, Aerosurf, lyophilized KL4 surfactant, oral ...
|
|
|
|